These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 3781686

  • 1. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D, Bonfiglioli D, Tirrito M, Pogliaghi I, Branchi A, Cabrini E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [Abstract] [Full Text] [Related]

  • 2. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB, Simpson HC, Slaughter P, Lousley S, Carter RD, Cobbe SM, Mann JI.
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 4. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G, Witztum J, Basich P.
    Artery; 1982 Jun 14; 10(2):99-104. PubMed ID: 7092583
    [Abstract] [Full Text] [Related]

  • 5. Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
    Steinhagen-Thiessen E, Müller S, Holler HD, Lang PD.
    Arzneimittelforschung; 1987 Jun 14; 37(6):726-8. PubMed ID: 3311054
    [Abstract] [Full Text] [Related]

  • 6. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 7. Mode of hypocholesterolemic action of probucol in animals and man.
    Beynen AC.
    Artery; 1987 May 25; 14(2):113-26. PubMed ID: 3551883
    [Abstract] [Full Text] [Related]

  • 8. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A, Arteaga A, Villanueva CL, Velasco N, Acosta AM.
    Rev Med Chil; 1990 Sep 25; 118(9):1009-13. PubMed ID: 2152729
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA, Toivonen I.
    Postgrad Med J; 1975 Sep 25; 51(8):suppl 71-5. PubMed ID: 215985
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 11. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
    Wissler RW, Vesselinovitch D.
    Appl Pathol; 1983 Feb 27; 1(2):89-96. PubMed ID: 6678159
    [Abstract] [Full Text] [Related]

  • 12. The long-term effects of probucol on serum lipid levels.
    McCaughan D.
    Arch Intern Med; 1981 Oct 27; 141(11):1428-32. PubMed ID: 7025778
    [Abstract] [Full Text] [Related]

  • 13. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B.
    Am J Cardiol; 1986 Jun 27; 57(16):29H-35H. PubMed ID: 3728307
    [Abstract] [Full Text] [Related]

  • 14. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    Krüger B.
    Int J Clin Pharmacol Res; 1994 Jun 27; 14(5-6):177-83. PubMed ID: 7672874
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 27; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 27; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 17. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R, Gasparotto A, Valerio G, Baiocchi MR, Padrini R, Lamon S, Vitale E, Baggio G, Crepaldi G.
    Atherosclerosis; 1986 Jan 27; 59(1):47-56. PubMed ID: 3081013
    [Abstract] [Full Text] [Related]

  • 18. High protein diet complements resin therapy of familial hypercholesterolemia.
    Wolfe BM, Giovannetti PM.
    Clin Invest Med; 1992 Aug 27; 15(4):349-59. PubMed ID: 1516292
    [Abstract] [Full Text] [Related]

  • 19. Lovastatin: cholesterol-lowering agent.
    DiPalma JR.
    Am Fam Physician; 1987 Dec 27; 36(6):189-92. PubMed ID: 3687679
    [No Abstract] [Full Text] [Related]

  • 20. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K, Fukushima N, Ozaki I, Setoguchi Y, Yanagita T, Sakai T.
    Artery; 1991 Dec 27; 18(3):133-49. PubMed ID: 2069518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.